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Abstract
Evidence suggests Ginsenoside Rd (GSRd), a biologically active extract from the medical plant Panax Ginseng, exerts
antioxidant effect, decreasing reactive oxygen species (ROS) formation. Current study determined the effect of GSRd on
myocardial ischemia/reperfusion (MI/R) injury (a pathological condition where ROS production is significantly increased) and
investigated the underlying mechanisms. The current study utilized an in vivo rat model of MI/R injury and an in vitro
neonatal rat cardiomyocyte (NRC) model of simulated ischemia/reperfusion (SI/R) injury. Infarct size was measured by Evans
blue/TTC double staining. NRC injury was determined by MTT and lactate dehydrogenase (LDH) leakage assay. ROS
accumulation and apoptosis were assessed by flow cytometry. Mitochondrial membrane potential (MMP) was determined
by 5, 59, 6, 69-tetrachloro-1, 19, 3, 39-tetrathylbenzimidazol carbocyanine iodide (JC-1). Cytosolic translocation of
mitochondrial cytochrome c and expression of caspase-9, caspase-3, Bcl-2 family proteins, and phosphorylated Akt and GSK-
3b were determined by western blot. Pretreatment with GSRd (50 mg/kg) significantly augmented rat cardiac function, as
evidenced by increased left ventricular ejection fraction (LVEF) and 6dP/dt. GSRd reduced myocardial infarct size, apoptotic
cell death, and blood creatine kinase/lactate dehydrogenase levels after MI/R. In NRCs, GSRd (10 mM) inhibited SI/R-induced
ROS generation (P,0.01), decreased cellular apoptosis, stabilized the mitochondrial membrane potential (MMP), and
attenuated cytosolic translocation of mitochondrial cytochrome c. GSRd inhibited activation of caspase-9 and caspase-3,
increased the phosphorylated Akt and GSK-3b, and increased the Bcl-2/Bax ratio. Together, these data demonstrate GSRd
mediated cardioprotective effect against MI/R–induced apoptosis via a mitochondrial-dependent apoptotic pathway.
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Introduction
Ginseng, the root of Panax ginseng C.A. Mayer (Araliaceae), is
a popular traditional Chinese medicinal herb. Although the
mechanisms responsible for ginseng’s various effects remain largely
unknown, several active ingredients termed ginsenosides have
been isolated from the plant [1–3]. Ginsenoside Rd, Dammer-
24(25)-ene-3b, 12b, 20(S)- triol-(20-O-b-D-glucopyranosyl)-3-O-b-
D-glucopyranosyl-(1R2)-b-D-gluco-pyranoside (GSRd,
C48H82O18?3H2O, molecular weight 1001, Figure 1), one of the
major P. ginseng isolates, scavenges free radicals [4,5], inhibits
Ca2+-influx via receptor and store-operated Ca2+ channels [6],
and protects against neuronal apoptosis [4,7]. Therefore, in
addition to being highly lipophilic and capable of easily diffusing
across biological membranes, GSRd may have significant advan-
tageous cardiac effects. However, it has not been investigated
whether GSRd exerts protective effect against myocardial
ischemia- reperfusion (MI/R) injury, or by what potential
mechanisms.
Toxic reactive oxygen species (ROS) generated during MI/R
both directly and indirectly affect cardiomyocyte function,
promoting apoptosis and necrosis [8]. Mitochondria are both a
major endogenous source and target of ROS, including superox-
ide anions, hydrogen peroxide, peroxynitrite, and hydroxyl
radicals. Mitochondrial dysfunction increases ROS production,
exacerbating oxidant-induced apoptosis [9,10]. During early
reperfusion, ROS burst alters intracellular redox states, modifies
the inner mitochondrial membrane potential (MMP), and releases
mitochondrial-cytochrome c into the cytosol, ultimately activating
caspase-3 in the final apoptotic pathway [11,12]. Preventing ROS
production and preserving mitochondrial integrity are therefore
protective against MI/R injury. Clinical evidence demonstrates
GSRd potently suppresses ROS generation [4,13]. It remains
unknown whether GSRd may decrease MI/R-induced ROS
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generation, or whether GSRd may inhibit the mitochondrial-
dependent apoptotic pathway.
The phosphatidylinositol-3-kinase (PI3K)/Akt pathway is car-
dioprotective against MI/R injury [14–16]. Additionally, PI3K/
Akt pathway activation attenuates mitochondria-mediated apop-
tosis [17,18]. Serine/threonine kinase Akt is a primary mediator of
the downstream effects of phosphatidylinositol-3 kinase (PI3K),
preserving mitochondrial integrity by phosphorylating molecules
such as the Bcl-2 family and GSK-3b [19]. Glycogen synthase
kinase 3b (GSK-3b) is a serine/threonine kinase; phosphorylated
GSK-3b is cardioprotective against MI/R injury [20]. Although
GSRd has been demonstrated to be anti-apoptotic by activating
PI3K/Akt [21], whether GSRd suppresses mitochondrial-depen-
dent apoptosis during MI/R via PI3K/Akt/GSK-3b signaling
remains unknown.
Therefore, the aims of this study were: 1) to determine whether
GSRd exerts any cardioprotective effect against MI/R injury; 2) to
determine whether GSRd may decrease oxidative stress in rats




This study was performed in adherence with the National
Institutes of Health Guidelines for the Use of Laboratory Animals,
and was approved by the Fourth Military Medical University
Committee on Animal Care. Male Sprague-Dawley (SD) rats
weighing 270–320 g were provided by the Experimental Animal
Center of the Fourth Military Medical University (Xi’an, China).
All animals were allowed free access to food and water, and were
maintained at 22–24uC under a 12 hour:12 hour light-dark cycle.
GSRd (purity 98%, Tai-He Biopharmaceutical Co. Ltd, Guangz-
hou, China) stock solutions were prepared in saline containing
10% 1, 3-propanediol (v/v). Fetal bovine serum (FBS) and
Dulbecco’s modified Eagle’s medium (DMEM) were from Gibco
(Grand Island, NY, USA). TUNEL apoptosis kit was from Roche
Diagnostics (Mannheim, Germany). Propidium iodide (PI),
Annexin-V, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), 29,79-dichorofluoresceine diacetate (DCFH-
DA), and 5,59,6,69-tetrachloro-1,19,3,39-tetraethyl-benzimidazol-
carbocyanine iodide (JC-1) were from Sigma-Aldrich Inc. (St.
Louis, MO, USA). Antibodies against Bcl-2, Bax, caspase3,
caspase9, cytochrome c, and b-actin were from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Antibodies against Akt,
phospho-Akt (Ser473), GSK-3b, and phosphor-GSK- 3b (Ser9)
were from Cell Signaling Technology (Beverly, MA, USA). All
other reagents were of standard biochemical quality from
commercial suppliers.
Myocardial ischemia/reperfusion (MI/R) model in rats
Adult male Sprague-Dawley rats were fasted overnight, and
anesthetized via intraperitoneal (IP) administration of 50 mg/kg
pentobarbital sodium. A micro-catheter was inserted into the left
ventricle through the right carotid artery to measure the left
ventricular pressure. Myocardial ischemia was produced after
exteriorizing the heart via a left thoracic incision, and placing a 6–
0 silk slipknot suture around the left anterior descending coronary
artery approximately 2–3 mm from its origin. Ischemia was
monitored and confirmed by ST segment elevation upon
electrocardiogram (ECG). After 30 minutes ischemia, the slipknot
was released, and myocardial reperfusion for 3 hours. Rats were
randomly assigned to one of the following treatments (n = 8/
group): 1) Sham group, receiving vehicle IP injection (10 ml/kg
saline) and operative procedures without coronary slipknot; 2) MI/
R group, receiving vehicle IP injection (10 ml/kg saline) 30 min-
utes prior to coronary I/R; and 3) MI/R+GSRd group, receiving
GSRd IP injection (50 mg/kg) 30 minutes prior to coronary I/R,
a dose established from prior investigations [13,22].
Isolation of primary neonatal rat cardiomyocytes and
simulated ischemia/reperfusion (SI/R)
Neonatal rat cardiomyocytes (NRCs) were isolated from 1–
2 day old Sprague-Dawley rats. Briefly, excised hearts were
washed in Hanks balanced salt solution (HBSS; Ca2+-Mg2+free).
Ventricles were freed of associated tissues, minced, subjected to 5–
6 0.125% trypsin washes (37uC), filtered, and centrifuged at
1,000 rpm for 10 minutes. Supernatant was resuspended in
DMEM containing 20% fetal bovine serum, penicillin (100 U/
mL), and streptomycin (100 U/mL). Resuspended cells were
placed in a petri dish in a humidified incubator (5% CO2, 37uC)
for 90 minutes to promote dish surface attachment of non-
myocytes suspended in solution. Cells were harvested and seeded
onto 60-mm culture dishes. 5-Bromo-29-deoxyuridine (100 mM)
was added during the first 48 hours to inhibit non-myocyte
proliferation. Simulated I/R (SI/R) was employed as previously
described [23]. Briefly, simulated ischemia buffer (composition in
mM: NaCl 98.5, KCl 10, MgSO4 1.2, CaCl2 1.0, HEPES 20,
sodium lactate 40, pH 6.8) and simulated reoxygenation buffer
(composition in mM: NaH2PO4 0.9, NaHCO3 20.0, CaCl2 1.0,
MgSO4 1.2, HEPES 20.0, NaCl 129.5, KCl 5.0, glucose 5.5,
pH 7.4) were prepared in advance. Confluent-beating cells in 6-
well plates were subjected to medium replacement with simulated
ischemia buffer, incubated in a hypoxic chamber (of humidified
atmosphere 5% CO2/0% O2 balanced with N2 at 37uC) for
3 hours, and then reoxygenated in a standard incubator for
2 hours with medium replacement with re-oxygenation buffer.
Cells subjected to control conditions were cultured with normal
Tyrode solution (pH 7.4) in a humidified atmosphere of 5% CO2/
21% O2 balanced with N2 at 37uC for 5 hours. Four separate
NRC groups were tested:
1) Control group, incubated with Tyrode solution for the entire
experimental period;
2) SI/R group, incubated with simulated ischemia buffer for 3
hours hypoxia, followed by 2 hours re-oxygenation;
Figure 1. The chemical structure of GSRd. The molecular formula
of GSRd (C48H82O18?3H2O). Its molecular weight is 1001.
doi:10.1371/journal.pone.0070956.g001
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3) Vehicle group, subjected to 0.2% (v/v) DMSO administration
30 minutes prior to SI/R;
4) SI/R+GSRd group, subjected to GSRd (10 mM) administra-
tion 30 minutes prior to SI/R, a dose selected based upon
dose-response experiments and previous investigations [5,24].
Determination of cardiac function
MI/R-induced cardiac dysfunction was determined by invasive
hemodynamic evaluation methods. A micro-catheter was inserted
into the left ventricle via the right carotid artery to measure the left
ventricular pressure (LVP). ECG and LVP were simultaneously
recorded on a polygraph (RM-6200C; Chengdu, Instrument,
Chengdu, China). Computer algorithms measured left ventricular
systolic pressure (LVSP), left ventricular end-diastolic pressure
(LVEDP), first derivative of left ventricular pressure (6dP/dtmax),
and heart rate (HR) at baseline, after 30 minutes ischemia, and
after 1, 2, and 3 hours of reperfusion.
Determination of myocardial infarct size
After reperfusion conclusion, the coronary artery ligature was
retied. 4 mL of 2% Evans blue dye (Shanghai Chemical Reagents,
Shanghai, China) was injected into the aorta. Dye was circulated
and uniformly distributed, except in the cardiac region previously
perfused by the occluded coronary artery (defining the ischemic
region or area at risk, AAR). Cardiectomy was rapidly performed.
Hearts were frozen at 220uC and sliced into 1-mm sections
perpendicular to the base-apex. Slices were incubated in 1% TTC
in phosphate buffer at 37uC for 10 minutes (pH 7.4). Morpho-
metric measurements of AAR and infarct area (INF) were
performed by image analysis system (Image-Pro plus; Media
Cybernetics, Bethesda, MA). Myocardial infarct size was expressed
as percentage of infarct area (INF) over total AAR (INF/
AAR6100%).
Determination of in vivo necrosis and cell death
Myocardial cellular damage and necrosis were evaluated by
measuring plasma levels lactate dehydrogenase (LDH) and
creatine kinase (CK). Blood samples (1mL) were drawn after
3 hours reperfusion. LDH and CK levels were measured in
blinded manner by spectrophotometry (DU 640; Beckman
Coulter, Brea, CA) in duplicate.
Determination of myocardial apoptosis
Myocardial apoptosis was determined by a commercially
available terminal deoxynucleotidyl nick-end labeling (TUNEL)
assay per manufacturer’s protocol. TUNEL-positive cardiomyo-
cytes in ischemic myocardium were counted in double-blinded
fashion. The percentage of TUNEL-positive cells was determined
by dividing the number of positive-staining nuclei by the total
number of nuclei in a given field of view (at 200 microscopic
magnification).
An additional test was performed to assess myocardial apoptosis
with greater specificity. Cardiac caspase-3 activity was determined
via caspase-3 colorimetric assay kit (Chemicon, Temecula, CA). In
brief, myocardial tissue was homogenized in ice cold lysis buffer
for 30 seconds. The homogenates were centrifuged. Supernatants
were collected, and protein concentrations were measured by
bicinchoninic acid method. To each well of a 96-well plate,
supernatant containing 200 mg of protein was loaded and
incubated with 25 mg caspase-3 substrate N-acetyl-Asp-Glu-Val-
Asp (DEVD)-p-nitroanilide at 37uC for 1.5 hours. The optical
density was measured at 405 nm with a SpectraMax-Plus
microplate spectrophotometer. Caspase-3 activity was calculated
Figure 2. Ginsenoside Rd improves rat cardiac function after 30 minutes ischemia and 3 hours reperfusion. Values presented are mean
6 SEM. Abbreviations: LVSP, left ventricular systolic pressure; LVEDP, left ventricular end diastolic pressure; 6LVdP/dtmax, the instantaneous first
derivation of left ventricle pressure; MI/R, myocardial ischemia/reperfusion (30 minutes/3 hours). n = 8/group. **P,0.01 vs. Sham, #P,0.05,
##P,0.01 vs. MI/R.
doi:10.1371/journal.pone.0070956.g002
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Figure 3. Ginsenoside Rd reduced rat myocardial injury (infarct size, necrosis, and apoptosis) post MI/R. (A) Myocardial infarct size in
rats subjected to 30 minutes I, followed by 3 hours R. Blue-staining represents non-ischemic tissue, red-staining represents the area at risk, and pale
areas indicate infracted regions. Myocardial infarct size (INF) expressed as percentage of area at risk (AAR). (B) Plasma creatine kinase (CK) and lactate
dehydrogenase (LDH) levels. (C) Left: Representative photomicrographs of in situ detection of apoptotic cardiomyocytes by terminal
deoxynucleotidyl nick-end labeling (TUNEL) staining in MI/R heart tissue. Green fluorescence indicates TUNEL-positive apoptotic nuclei; blue
fluorescence indicates total cardiomyocyte nuclei. Original magnification 2006; Right: Percentage of TUNEL-positive nuclei in heart tissue sections.
(D) Myocardial caspase-3 activity. All values presented are mean 6 SEM. n = 8/group. **P,0.01 vs. Sham, #P,0.05, ##P,0.01 vs. MI/R.
doi:10.1371/journal.pone.0070956.g003
Figure 4. Ginsenoside Rd ameliorated SI/R-induced in vitro cell injury (viability, death, and apoptosis). (A) GSRd treatment alone (0.1–
50 mM) for 24 hours did not alter NRC viability, suggesting no GSRd-induced toxicity at concentrations up to 10 mM (n= 8; *P.0.05 vs. Control). (B)
Cellular viability as determined by MTT assay after SI/R (3 hours hypoxia followed by 2 hours reoxygenation). (C) Cellular death post GSRd treatment
alone for 24 hours as determined by LDH leakage into medium (n= 8; *P.0.05 vs. Control). (D) LDH assay in cells administered GSRd (0.1, 1, 10 mM)
30 minutes prior to SI/R. (E) SI/R-induced apoptosis as determined by Annexin V-FITC/PI flow cytometry in control and vehicle groups. (F) 10 mM
GSRd significantly reduced SI/R-induced apoptosis as determined by Annexin V-FITC/PI flow cytometry. All values presented are mean 6 SEM.
**P,0.01 vs. Control, #P,0.05, ##P,0.01 vs. SI/R. These experiments were performed in triplicate with similar results.
doi:10.1371/journal.pone.0070956.g004
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using a standard curve and expressed as fold increase over the
mean value of sham MI.
Determination of cellular viability
Cellular viability was determined by MTT assay. NRCs were
distributed into a 96-well plate (density 16105 cells/well), and
pretreated with different GSRd concentrations (0.1–50 mM). After
experimental treatment, MTT was added to each well (final
concentration 0.5 mg/mL). Plates were incubated for 4 hours at
37uC. Absorbance of blue formazan derivative, indicating
viability, was measured at 570 nm via microplate reader (Bio-
Rad Laboratories, CA, USA). All measurements were performed
in duplicate.
Determination of in vitro cellular injury
Cellular injury was determined by LDH release. 0.2 mL of
culture medium from NRCs post H/R treatment was analyzed by
spectrophotometry via commercial assay kit (UV-120-02, Shang-
hai, China), per manufacturer’s protocol. Cellular LDH release
was expressed as the percentage of total cell LDH activity. All
measurements were performed in duplicate.
Determination of apoptosis by flow cytometry
The NRC apoptotic ratio was determined by flow cytometry
with annexin V-FITC/PI staining per manufacturer’s protocol. In
brief, NRCs were plated upon a six-well plate, and pretreated with
10 mM GSRd for 30 minutes followed by SI/R treatment. After
experimental treatment, cells were collected, washed with calcium-
free PBS, and resuspended in binding buffer. Cells were treated
with annexin V-FITC and PI, placed in the dark at room
temperature for 15 minutes, and analyzed by a Beckton-Dickinson
flow cytometer (FACS).
Measurement of intracellular reactive oxygen species
ROS generation was determined by fluorescent probe DCFH-
DA. Cell-permeable non-fluorescent DCFH-DA oxidizes to the
highly fluorescent 2,7-dichlorofluorescin in ROS presence. NRCs
were plated upon a six-well plate, and pretreated with 10 mM
GSRd for 30 minutes followed by SI/R treatment. Cells were
harvested by trypsinization. After two PBS washings, 10 mM
DCFH-DA was added for 20 minutes at 37uC in the dark.
Fluorescence intensity was measured by flow cytometry (Coulter,
USA) at excitation wavelength 488 nm, and emission wavelength
525 nm.
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential (MMP) was evaluated by
cationic dye JC-1. In normal cells, JC-1 aggregates in mitochon-
dria, fluorescencing red. In apoptotic cells, JC-1 accrues in the
cytosol, as a green fluorescencing monomer. At the experiment’s
conclusion, 16106 cells were harvested by trypsinization. After
two PBS washings, cells were incubated with JC-1 10 mg/mL for
15 minutes at 37uC in the dark. Cells were harvested, suspended
in PBS, and analyzed by flow cytometry.
Western blot analysis
Whole cell extracts were prepared as follows: Cultured NRCs
were washed twice with cold PBS and immersed in lysis buffer
(composition: 50 mM HEPES, pH 7.4, 0.1% Chaps, 5 mM DTT,
0.1 mM EDTA, and 0.1% Triton X-100). Cell lysates were
centrifuged. Protein concentrations in the supernatants were
Figure 5. Ginsenoside Rd reduces intracellular ROS generation in NRCs subjected to SI/R. Intracellular ROS accumulation was measured
via fluorescence probe DCFH-DA. Fluorescent intensity was determined at excitation wavelength 488 nm and emission wavelength 525 nm via flow
cytometry. Values presented are mean 6 SEM. **P,0.01 vs. Control, #P,0.05 vs. SI/R. These experiments were performed in triplicate with similar
results.
doi:10.1371/journal.pone.0070956.g005
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determined by Bradford Protein Assay Kit (Bio-Rad, CA, USA).
Equal samples were loaded onto and separated by 12% SDS-
polyacrylamide gel electrophoresis. Proteins were transferred to
nylon membranes by electrophoretic transfer system (Bio-Rad).
Membranes were blocked in 5% skim milk for 1 hour at room
temperature. Incubation with primary antibody commenced
overnight at 4uC, followed by secondary antibody conjugated to
horseradish peroxidase for 2 hours. Immunoblot was visualized
with ChemiDocXRS (Bio-Rad Laboratory, Hercules, CA), and
analyzed with LabImage software.
Statistical analysis
All values are presented as mean6SEM. Differences were
evaluated by AVOVA followed by Bonferroni correction for post
hoc t-test, where appropriate. P values less than 0.05 were
considered significant. All statistical tests were performed with
GraphPad Prism software, version 5.0 (GraphPad Software, San
Diego, CA).
Results
Ginsenoside Rd improves rat cardiac function after MI/R
GSRd had no effects on blood glucose, blood pressure and
cardiac function in the absence of MI/R. No significant
hemodynamic differences existed between groups at baseline
conditions. Additionally, there were no significant differences in
heart rate (HR) and mean arterial pressure (MAP) between any
groups during MI/R. Pretreatment with GSRd enhanced 6
LVdP/dt max after 3 hours reperfusion compared to MI/R group
(Figure 2). Additionally, GSRd markedly decreased LVEDP post-
I/R compared to MI/R group (P,0.01). Hemodynamic data
support GSRd improved rat cardiac systolic and diastolic function
after MI/R.
Ginsenoside Rd reduced rat myocardial injury (infarct
size, necrosis, and apoptosis) post MI/R
Myocardial infarct size and plasma CK and LDH were
measured to assess myocardial injury post I/R. Representative
AAR and INF images are shown in Figure 3A. No myocardial
infarction was observed in sham-group hearts. 30 minutes MI
followed by 3 hours R resulted in significant infarction in MI/R
group rats compared to sham (36.0%61.5% versus sham,
P,0.01). GSRd treatment significantly decreased infarct size
(20.9%62.3% versus 36.0%61.5% MI/R-group, P,0.01). There
was no significant difference in AAR between all groups.
Cardiomyocyte necrosis is characterized by cellular content
release. To determine whether GSRd attenuated MI/R-induced
cardiomyocyte necrosis, plasma CK and LDH levels were
measured after reperfusion conclusion. Plasma CK and LDH
levels increased to 3,3246228 and 2,3276143U/L respectively in
the MI/R-group (Figure 3B). GSRd treatment markedly de-
creased CK and LDH levels (2,2386160 and 1,3206109 U/L
respectively, P,0.01) in the MI/R group. These indicators
support GSRd decreased in vivo myocardial necrosis post-MI/R.
Apoptosis is the major mechanism of cell death immediately
following a short period of ischemia with ensuing reperfusion, and
was assessed by two methods, TUNEL staining and caspase-3
activity. As expected, TUNEL-positively staining cells were
minimally detected (3.0%61.2%) in the sham-group (Figure 3C),
Figure 6. Ginsenoside Rd increases mitochondrial membrane potential (MMP) in NRCs subjected to SI/R. MMP was measured with
fluorescent dye JC-1. 10 mM GSRd was administered 30 minutes prior to SI/R. Fluorescent intensity of JC-1 was determined at excitation wavelength
488 nm and emission wavelength 530 nm via flow cytometry. Values presented are mean 6 SEM. **P,0.01 vs. Control, ##P,0.01 vs. SI/R. These
experiments were performed in triplicate with similar results.
doi:10.1371/journal.pone.0070956.g006
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whereas the MI/R group exhibited a significant number of
TUNEL-positively cells (16.3%61.8%). GSRd pretreatment
significantly reduced TUNEL-positively staining cells
(11%62.3%). Myocardial caspase-3 activity is a very specific
indicator of cardiomyocyte apoptosis. Consistent with TUNEL
results, the MI/R group exhibited significantly increased caspase-3
activity (3.060.2 versus 0.960.2, P,0.01, Figure 3D). GSRd
substantially reduced caspase-3 activity compared to the MI/R-
group (1.960.3 versus 3.060.2, P,0.05). Together, these data
suggest GSRd decreased post-MI/R myocardial apoptosis in vivo.
Ginsenoside Rd ameliorated in vitro cell death (viability,
death, and apoptosis) post SI/R
To first determine the effects of GSRd alone upon NRCs, cells
were treated with varying concentrations of GSRd (0.1–50 mM).
GSRd alone at these concentrations for 24 hours was not cytotoxic
by MTT and LDH leakage assay (Figure 4A, 4C). Concentration
response curves determining cellular viability are shown in
Figure 4B. Peak cellular viability was observed at GSRd dose
10 mM.
Cellular viability and LDH leakage are indices of NRCs injury.
After being subject to SI/R, cellular viability in the vehicle group
was significantly reduced 41%60.6% compared to control, and
LDH leakage increased 16.33%62.3% compared to control (all
P,0.01). GSRd (0.1, 1, and 10 mM) markedly reduced SI/R-
induced cell death, respectively increasing viability rate to
59%61.8%, 63%63.9%, and 69%63.7% and decreasing LDH
leakage to 11%61.7%, 10.3%60.9%, and 7.3%60.9% (P,0.01,
Figure 4B, 4D). Together, these results indicate GSRd significantly
preserved cellular viability post-SI/R injury in a dose-dependent
manner (at concentrations up to 10 mM).
Cellular apoptosis was assessed by flow cytometry (Figure 4E).
Annexin V/PI double staining demonstrated significant apoptotic
increase in vehicle group compared to control post SI/R
(19.9%61.1% versus 3.1%60.2%, P,0.01). 10 mM GSRd
markedly decreased apoptosis (6.3%60.7%, P,0.01, Figure 4F).
Taken together, these in vitro results support GSRd as a potent
cardioprotective agent, in consistent fashion with in vivo data.
Ginsenoside Rd reduces intracellular ROS generation,
increases mitochondrial membrane potential (MMP), and
decreases cytochrome c release in NRCs subjected to SI/R
Intracellular ROS levels were assessed by determining DCF
fluorescence intensity via flow cytometry. SI/R induced rapidly and
significantly increased DCF fluorescence (P,0.01, Figure 5A).
Figure 7. Ginsenoside Rd inhibits mitochondrial-mediated apoptosis in NRCs subjected to SI/R. (A) Representative western blot for
cytochrome c release. SI/R increased cytosolic translocation of mitochondrial cytochrome c. Densitometric analysis demonstrates 10 mM GSRd
inhibited mitochondrial cytochrome c release. (B) Representative western blot for Bcl-2 and Bax expression after various experimental treatments.
Densitometric analysis demonstrates SI/R reduced the Bcl-2/Bax ratio, but GSRd increased the Bcl-2/Bax ratio. (C) Representative western blot for SI/R-
induced casepase-3 and caspase-9 activation. Densitometric analysis demonstrates 10 mM GSRd reduced expression of cleaved caspase-9 and
caspase-3. All values presented are mean6SEM. n = 6; **P,0.01 vs. Control, #P,0.05, ##P,0.01 vs. SI/R.
doi:10.1371/journal.pone.0070956.g007
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However, pretreatment of NRCs prior to SI/R significantly
decreased DCF fluorescence (P,0.05, Figure 5B), suggesting GSRd
significantly reduced ROS generation during SI/R in NRCs.
Mitochondrial membrane potential (MMP) is an important early
determinant of the mitochondrial apoptotic pathway. We investi-
gated the effects of GSRd upon MMP and cytochrome c release.
MMP detection was performed utilizing JC-1 dye to assess
mitochondrial membrane depolarization. NRCs subjected to SI/
R exhibited substantially decreased mitochondrial depolarization
compared to control (P,0.01, Figure 6A). Pretreatment with 10 mM
GSRd significantly stabilized the MMP (P,0.01, Figure 6B).
Mitochondrial depolarization releases several apoptogenic proteins,
most notably cytochrome c into the cytosol. Western blot analysis
demonstrated SI/R increased mitochondrial cytochrome c release
into cytosol, and 10 mM GSRd decreased cytochrome c release
(0.960.03 versus 0.760.02, P,0.05, Figure 7A). Together, these
results suggest GSRd may attenuate apoptosis by potentially
involving the mitochondrial apoptotic pathway.
Ginsenoside Rd modulates Bcl-2 and Bax expression in
NRCs subjected to SI/R
Next, we determine whether GSRd protects against SI/R-
induced apoptosis in NRCs by modulating the Bcl-2 family
proteins. SI/R treatment decreased Bcl-2 (an anti-apoptotic
protein) expression, and increased Bax (a pro-apoptotic protein)
expression, decreasing the Bcl-2/Bax ratio (Figure 7B). Pretreating
NRCs with 10 mM GSRd prior to SI/R promoted Bcl-2
expression and inhibited Bax expression, increasing the Bcl-2/
Bax ratio (Figure 7B).
Ginsenoside Rd decreases caspase-3 activity in NRCs
subjected to SI/R
Caspases regulate cellular apoptosis. Cytochrome c release
activates caspase-9, which activates caspase-3. SI/R significantly
increased expression of both cleaved caspase-9 and caspase-3,
which was attenuated by 10 mM GSRd pretreatment (Figure 7C).
Figure 8. Ginsenoside Rd increases phosphorylation of Akt and GSK-3b in NRCs subjected to SI/R. Densitometric analysis demonstrates
GSRd increased the ratio of P-Akt/Akt and P-GSK-3b/GSK-3b, which was significantly blocked by Akt-inhibitor LY294002. Values presented are
mean6SEM. n = 6; #P,0.05, ##P,0.01 vs. SI/R, &&P,0.01 vs. SI/R+GSRd.
doi:10.1371/journal.pone.0070956.g008
Figure 9. Schematic diagram depicting protective signaling of
GSRd in MI/R-induced apoptosis. GSRd inhibits the apoptotic
signaling cascades initiated by MI/R-generated ROS. Arrows (R)
indicate activation or induction, and segments ending with a (w)
indicate inhibition/blockade. Solid lines (—) indicate mechanisms
strongly supported by the current study, and dotted lines (--) indicate
hypothesized connections requiring further investigations.
doi:10.1371/journal.pone.0070956.g009
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Ginsenoside Rd increases phosphorylation of Akt and
GSK-3b in NRCs subjected to SI/R
To further investigate the molecular mechanism underlying
GSRd-mediated cardioprotection, we determined P-Akt/Akt and
P-GSK-3b/GSK-3b in NRCs post SI/R by western blot. There
was no significant difference in Akt and GSK-3b expression
between treatment groups at baseline (Figure 8). Consistent with
previous reports, SI/R alone increased phosphorylation of Akt and
GSK-3b. Pretreatment with 10 mM GSRd significantly increased
phosphorylation of Akt and GSK-3b (and consequently increased
P-Akt/Akt and P-GSK-3b/GSK-3b ratios, P,0.01). Pretreatment
with PI3K inhibitor LY294002 blocked GSRd-mediated phos-
phorylation of Akt and GSK-3b.
Discussion
Several important observations were made in the present study.
Firstly, we demonstrate that pretreatment with GSRd attenuated
in vivo MI/R injury in a rat model (evidenced by improved
cardiac function, reduced infarct size, and reduced myocardial
apoptosis after MI/R), and reduced in vitro SI/R injury in
cultured NRCs (evidenced by increased cardiomyocyte viability,
decreased cardiomyocyte LDH activity, and reduced cardiomyo-
cyte caspase-3 and -9 cleavage). Secondly, we provide the first
evidence that GSRd reduces intracellular ROS generation in
cardiomyocytes, and inhibits myocardial apoptosis induced by SI/
R via the mitochondrial-dependent apoptotic pathway. Finally, we
demonstrate Akt/GSK-3b signaling pathway activation signifi-
cantly contributes to the anti-apoptotic effect of GSRd.
The medical herb ginseng is used worldwide. Ginsenosides,
triterpene saponins, are a major ginseng component. More than
40 ginsenosides have been identified. Previous studies demonstrate
ginsenosides have significant protective effects in the cardiovascu-
lar system [25–27]. Wang et al. studied MI/R injury in an in vivo
rat model, and reported ginsenoside reduced infarct size and
improved resultant myocardial pathologic changes [28]. In a cell
culture model, Chen et al. reported panax notoginseng saponins
prevented cardiomyocyte apoptosis induced by glucose and
oxygen deprivation injury via PI3K/Akt signaling [29]. The
ginsenoside GSRd is highly lipophilic, and easily diffuses across
biological membranes [5]. Heretofore, its effects against MI/R
injury have never been investigated. Ginsenoside Rb1 and Re
have been demonstrated to exert direct depressant action upon
cardiomyocytes contraction, mediated in part via increased NO
production, reducing afterload and improving cardiac pump
function [30]. In our current study, GSRd augmented cardiac
function, increasing 6LVdP/dt max and decreasing LVEDP, and
reduced intracellular cardiomyocytes ROS generation. Further
investigation will be necessary to dissect the mechanisms
responsible for such divergent phenomenon. Nevertheless, our
study supports in consistent fashion the potential beneficial clinical
applications of GSRd.
During physiological conditions, a critical balance exists
between free radical production and the endogenous antioxidant
system [31,32]. Pathological conditions such as ischemia and
reperfusion tilt the balance in favor of ROS overproduction,
increasing oxidative stress, a major apoptotic stimulus. Pharma-
ceutics inhibiting ROS formation or antagonizing ROS toxicity
are cardioprotective against reperfusion injury [12,33,34]. In the
current study and many others, MI/R injury caused infarction
and cardiac dysfunction. SI/R injury in cultured NRCs induced
significant cell death. GSRd both limited infarct size and
augmented cardiac function in the employed rat MI/R model.
GSRd attenuated cellular damage (measured by MTT viability
and LDH activity assays) in cultured NRCs subjected to SI/R.
Cardiomyocyte apoptosis is one of the major pathogenic
mechanisms underlying MI/R injury [34]. Cumulative evidence
suggests that ROS, implicated in reperfusion toxicity, can trigger
cardiomyocyte apoptosis via the mitochondrial apoptosis pathway
[11,35,36]. ROS released during the early phase of myocardial
reperfusion strongly oxidizes cardiomyocytes already been dam-
aged by ischemia. Cardiomyocytes are rich in mitochondria, a
major endogenous source and susceptible target of ROS damage
[37]. Mitochondrial-mediated apoptosis plays an important role in
MI/R injury pathogenesis [8]. Under normal conditions,
cytochrome c is located within mitochondria. During intracellular
ROS overproduction, collapse of the mitochondrial membrane
potential (MMP) results in mitochondrial permeability transition
pore (mPTP) opening, and rapidly releasing cytochrome c into the
cytoplasm. Once released, cytochrome c binds the C- terminal
domain of the apoptotic protease activating factor-1 (Apaf-1),
inducing a conformation change. The activated Apaf-1/cyto-
chrome c complex promotes caspase activation [38]. Caspases
transduce and execute apoptotic signaling [11]. Caspase-3 (of the
terminal common apoptotic pathway) is also activated by caspase-
9, which is activated by the mitochondria-mediated apoptotic
pathway. In the current study, we demonstrate GSRd pretreat-
ment mitigated SI/R-induced intracellular ROS, MMP, and
mitochondrial release of cytochrome c into the cytosol, suggesting
involvement of the mitochondrial pathway in GSRd-mediated
cardioprotection.
The Bcl-2 protein family, compromised of both anti-and pro-
apoptotic members, are important mitochondrial regulators
during cardiomyocyte apoptosis [12]. Bcl-2 regulates mPTP
opening in opposition to Bax, blocking cytochrome c release,
inhibiting caspase activity, and decreasing cell apoptosis [39,40].
Therefore, altering the Bcl-2/Bax ratio influences apoptotic
balance. Western blot revealed SI/R significantly decreased the
Bcl-2/Bax ratio, an effect reversed by GSRd administration,
suggesting GSRd-mediated cardioprotection against SI/R injury
may occur partially via modulating Bcl-2/Bax expression.
The serine survival kinase Akt is activated downstream of
phosphatidylinositol 3-kinase (PI3K). Activation of PI3K and Akt
is cardioprotective against MI/R injury, and prevents cardiomyo-
cyte apoptosis [41,42]. Akt overexpression in cultured cardiomyo-
cytes preserves mitochondria Bcl-2 levels [18]. Akt exerts its
protective effects via phosphorylation of diverse target molecules
(such as Bcl-2 family and GSK-3), preserving mitochondrial
integrity. A downstream effector of Akt, GSK-3b is phosphorylated
at Ser 9 by Akt; phosphorylated GSK-3b attenuates MI/R injury
[20]. Phosphorylated GSK-3b suppresses mPTP opening by
binding to adenine nucleotide translocase (ANT, one of the mPTP
components), thereby reducing the affinity of ANT for cyclophilinD
[39]. In the present study, SI/R increased Akt and GSK-3b
phosphorylation, consistent with previous reports demonstrating
cardioprotective PI3K/Akt signaling in settings such as precondi-
tioning [19,43]. GSRd pretreatment further augmented Akt and
GSK-3b phosphorylation and attenuated cellular apoptosis. The
PI3K inhibitor LY294002 partially blocked the effects of GSRd.
Together, these results support mechanistic involvement of Akt/
GSK-3b signaling pathway in GSRd-mediated anti-apoptotic
effect.
Several limitations exist in the current study. Phosphorylation of
Akt by GSRd and its inhibition by LY294002 provide strong
supportive evidence for the involvement of Akt/GSK-3b in
GSRd-induced MI/R protection. However, it is not clear
LY294002 completely reverses GSRd’s effect upon cellular
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apoptosis. Additionally, while Akt overexpression preserves
mitochondrial Bcl-2 levels [18], but the specific mechanism by
which GSRd activates Akt to modulation the Bcl-2/Bax ratio
remains unknown, and warrants further investigation.
Taken together, our results demonstrate for the first time that
GSRd exerts cardioprotection against myocardial MI/R injury by
both reducing intracellular ROS and inhibiting mitochondria-
mediated apoptosis. Activation of Akt/GSK-3b signaling is
involved in the cardioprotective effect of GSRd (Figure 9). The
traditional herbal medicine GSRd may have therapeutic potential
attenuating myocardial ischemia/reperfusion injury.
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